Small integral membrane protein 44 (SMIM44)

Small integral membrane protein 44 (SMIM44) is a predicted integral membrane protein encoded by the SMIM44 gene in humans[1][5]. The protein is annotated as a protein-coding gene product and is predicted to localize to cellular membranes[1]. There is currently no experimentally validated information regarding its molecular function, expression profile, physiological role, involvement in human disease, or interaction with known drugs[1][4][5][6]. As such, SMIM44 is not recognized as a therapeutic target, biomarker, or disease-associated gene to date, and its precise biological significance remains unknown. All available information is based on gene annotation and bioinformatic prediction rather than experimental evidence[1][4][5].\n\nKey notes:\n- **SMIM44 is not an established therapeutic target** (no evidence for receptor, enzyme, transporter, or signaling molecule function)[1][4][5].\n- **Aliases include**: SMIM44, CTF5, NFI1_HUMAN, NFI2_HUMAN[1].\n- **No functional, disease, or drug-related data are available**.\n- **This entry may be flagged as \"incorrect\"** for most therapeutic or biomarker contexts due to lack of evidence for biological activity, disease relevance, or established molecular function[1][4][5].\n\nIf more comprehensive information about this protein become available, including experimentally validated function or links to disease, this evaluation should be updated accordingly.

Other names

SMIM44CTF5NFI1_HUMANNFI2_HUMANsmall integral membrane protein 44